DDIT3 and diffuse large B-cell lymphoma: Moreover, stromal gene signatures, which predicted survival in patients treated with CHOP and R-CHOP, were identified in DLBCL through the separate analysis of the neoplastic and non-neoplastic subpopulation by means of flow cytometry.